Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

Clicks: 356
ID: 272247
2006
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #61 of 161 articles by views in Lancet (London, England)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 161 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Oral MPT is an effective first-line treatment for elderly patients with multiple myeloma. Anticoagulant prophylaxis reduces frequency of thrombosis. Longer follow-up is needed to assess effect on overall survival.
Reference Key
a2006lancetoral Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Palumbo A;Bringhen S;Caravita T;Merla E;Capparella V;Callea V;Cangialosi C;Grasso M;Rossini F;Galli M;Catalano L;Zamagni E;Petrucci MT;De Stefano V;Ceccarelli M;Ambrosini MT;Avonto I;Falco P;Ciccone G;Liberati AM;Musto P;Boccadoro M; ;;
Journal Lancet (London, England)
Year 2006
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.